Skip to main navigation Skip to search Skip to main content

Azacitidine-eligibility in higher-risk myelodysplastic syndromes and chronic myelomonocytic leukaemia: A registry-based study

  • Senthilkumar Durairaj
  • , Norene Keenan
  • , Ann Hyslop
  • , Michael J. Groves
  • , David T. Bowen
  • , Sudhir Tauro

    Research output: Contribution to journalLetterpeer-review

    Original languageEnglish
    Pages (from-to)280-282
    Number of pages3
    JournalBritish Journal of Haematology
    Volume161
    Issue number2
    DOIs
    Publication statusPublished - Apr 2013

    Cite this